Personnel
William Claypool, MD, appointed to board of morphogenics-focused biotech company
Published in Gene Therapy Weekly, April 7th, 2005
Claypool currently is chief executive officer and chairman of the board of Phoenix Data Systems, Inc. Prior to his current position, he held a number of senior level management positions in the areas of worldwide clinical development, project management, R&D portfolio management, and medical affairs at both SmithKline Beecham Pharmaceuticals and G.D. Searle, Inc.
Claypool is a graduate of the University of Notre Dame and received his medical degree from the University of Connecticut School of Medicine. He performed his medical residency and pulmonary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-04-07)
More Articles from Gene Therapy Weekly
- Colon Cancer
Gene replacement therapy suppresses colorectal tumors in animal models - Neuroscience
Marrow stromal cells aid axonal regeneration after spinal cord injury - Oncology
Progression-elevated gene-3 promoter selects cancer cells for gene delivery - Renal Cancer
Antisense oligonucleotide to Ki-67 limits tumor growth but not vessel density - Age-Related Macular Degeneration
Gene believed responsible for age-related macular degeneration discovered - Allergy and Immunology
RNA transcripts are targets for asthma therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
